Drug development and industrial pharmacy

Development and testing of risperidone nanoparticles for delivery through the nose

Updated

Abstract

Risperidone nanoparticles (RP12) achieved a maximum plasma concentration of 1240 ng/ml at 4 hours.

  • Risperidone loaded chitosan nanoparticles were produced with an average size of 86 nm.
  • The nanoparticles exhibited a polydispersity index of 0.287 and a zeta potential of +36.6 mV.
  • Mucoadhesion was measured at 68.9%, and entrapment efficiency was found to be 77.96%.
  • Controlled drug release followed a Fickian diffusion mode.
  • Risperidone nanoparticles significantly reduced the stereotypy score in experimental animals with induced psychosis.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free